This proposal is a continuation and extension of work begun during the previous funding period which was aimed at the development of valid behavioral tests modeling cocaine-seeking behaviors for the evaluation of the therapeutic efficacy of potential treatment drugs for cocaine dependence. These animals models were designed to permit assessment of treatment drug effects on cocaine reward magnitude, strength of cocaine- seeking behaviors (""""""""craving""""""""), and the """"""""propensity to relapse"""""""". Results indicate that reliable measures of these behaviors can be established using progressive ratio and multiple schedules of reinforcement combined with tests of extinction and recovery. The objective of this application is to extend the scope of the previous proposal in three important respects: First, using the using the behavioral models established during the administration will be compared to those exhibited by rats given extended access to cocaine. Second, while the behavioral models will continue to be applied to the testing of potential treatment drugs with diverse pharmacological profiles, treatment drug tests will focus on the evaluation of agents that directly or indirectly interact wit mesocorticolimbic dopaminergic (DA) neurotransmission, in particular DA, D1, D2, and D3, agonists and antagonists, serotonin 5-HT, 5-HT2, 5-HT3 agonists and antagonists, cholecystokinin CCKa and CCKb agonists and antagonists, as well as a competitive NMDA glutamate antagonist. Third, the propose studies will examine whether the behavioral manifestations of cocaine """"""""craving"""""""" are subserved by the same or different neuropharmacological substrates as the acute reinforcing effects of cocaine. To accomplish these goals, the relative efficacy and nature of the modification by neurotransmitter-specific and receptor subtype- selective pharmacological agents of individual cocaine-seeking behaviors in both the limited-and extended-access situations will be evaluated. Finally, the baseline behavioral performance and test drug effects of rats trained under limited cocaine access conditions will be compared to that of rats receiving repeated exposure to extended-access cocaine self- administration. These studies will provide important, presently unavailable, insights on the relationship between self-administration history and cocaine cocaine-seeking behaviors, as well as information about the neuropharmacological substrate(s) mediating specific cocaine- seeking behaviors. Finally, the work in this proposal has valuable clinical implications with regard to the therapeutic potential of specific drugs in treating or preventing cocaine abuse and dependence.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
2R01DA007348-03A1
Application #
2119825
Study Section
Special Emphasis Panel (SRCD)
Project Start
1991-08-01
Project End
1997-03-31
Budget Start
1994-04-15
Budget End
1995-03-31
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Martin-Fardon, Rémi; Cauvi, Gabrielle; Kerr, Tony M et al. (2018) Differential role of hypothalamic orexin/hypocretin neurons in reward seeking motivated by cocaine versus palatable food. Addict Biol 23:6-15
Martin-Fardon, Rémi; Weiss, Friedbert (2017) Perseveration of craving: effects of stimuli conditioned to drugs of abuse versus conventional reinforcers differing in demand. Addict Biol 22:923-932
Matzeu, Alessandra; Cauvi, Gabrielle; Kerr, Tony M et al. (2017) The paraventricular nucleus of the thalamus is differentially recruited by stimuli conditioned to the availability of cocaine versus palatable food. Addict Biol 22:70-77
Matzeu, Alessandra; Kerr, Tony M; Weiss, Friedbert et al. (2016) Orexin-A/Hypocretin-1 Mediates Cocaine-Seeking Behavior in the Posterior Paraventricular Nucleus of the Thalamus via Orexin/Hypocretin Receptor-2. J Pharmacol Exp Ther 359:273-279
Matzeu, A; Weiss, F; Martin-Fardon, R (2015) Transient inactivation of the posterior paraventricular nucleus of the thalamus blocks cocaine-seeking behavior. Neurosci Lett 608:34-9
Martin-Fardon, Rémi; Weiss, Friedbert (2014) Blockade of hypocretin receptor-1 preferentially prevents cocaine seeking: comparison with natural reward seeking. Neuroreport 25:485-8
Martin-Fardon, Rémi; Weiss, Friedbert (2012) (-)-2-oxa-4-aminobicylco[3.1.0]hexane-4,6-dicarboxylic acid (LY379268) and 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine (MTEP) similarly attenuate stress-induced reinstatement of cocaine seeking. Addict Biol 17:557-64
Hao, Yue; Martin-Fardon, Rémi; Weiss, Friedbert (2010) Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: factor in the transition to dependence. Biol Psychiatry 68:240-8
Martin-Fardon, Rémi; Zorrilla, Eric P; Ciccocioppo, Roberto et al. (2010) Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin. Brain Res 1314:145-61
Martin-Fardon, R; Baptista, M A S; Dayas, C V et al. (2009) Dissociation of the effects of MTEP [3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine] on conditioned reinstatement and reinforcement: comparison between cocaine and a conventional reinforcer. J Pharmacol Exp Ther 329:1084-90

Showing the most recent 10 out of 39 publications